Select Medical Holdings (SEM) Depreciation & Amortization (CF) (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $37.7 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 8.21% year-over-year to $37.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.2 million (down 22.46% YoY) and the FY2025 annual result came in at $140.3 million, down 31.19% from the prior year.
• Depreciation & Amortization (CF) climbed to $37.7 million in Q1 2026 per SEM's latest filing, from $36.2 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $54.1 million in Q1 2024 and bottomed at $34.4 million in Q3 2025.
• The 5-year median for Depreciation & Amortization (CF) is $51.0 million (2022), against an average of $46.8 million.
• The widest annual swing landed in 2025, when Depreciation & Amortization (CF) plunged 35.62%; it then rose 8.21% in 2026.
• Tracing SEM's Depreciation & Amortization (CF) over 5 years: stood at $52.2 million in 2022, then increased by 3.33% to $54.0 million in 2023, then retreated by 15.27% to $45.7 million in 2024, then decreased by 20.85% to $36.2 million in 2025, then grew by 4.04% to $37.7 million in 2026.
• Per Business Quant, the three latest SEM Depreciation & Amortization (CF) figures stand at $37.7 million (Q1 2026), $36.2 million (Q4 2025), and $34.4 million (Q3 2025).

Peer Comparison